Cargando…

Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone

INTRODUCTION: Uric acid and edaravone might exert a neuroprotective effect in amyotrophic lateral sclerosis (ALS) by reducing oxidative stress. We analyzed whether the treatment effect of edaravone is pronounced in patients whose uric acid level increased after the treatment with edaravone. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Hee Jo, Shin, Ha Young, Choi, Young-Chul, Kim, Seung Min, Kim, Seung Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933037/ https://www.ncbi.nlm.nih.gov/pubmed/35296219 http://dx.doi.org/10.1080/13510002.2022.2051964

Ejemplares similares

Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
por: Park, Jin-Mo, et al.
Publicado: (2019)

Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis
por: Oh, Seong-il, et al.
Publicado: (2015)

Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
por: Cho, HaEun, et al.
Publicado: (2020)

Ethnical Disparities in Response to Edaravone in Patients With Amyotrophic Lateral Sclerosis
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis
por: Okada, Masamitsu, et al.
Publicado: (2018)

Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19
por: Al-Chalabi, Ammar, et al.
Publicado: (2021)

How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
por: Watanabe, Kazutoshi, et al.
Publicado: (2018)

Renal function in amyotrophic lateral sclerosis patients on long-term treatment with edaravone
por: Kakimoto, Asako, et al.
Publicado: (2021)

Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
por: Cha, Sun Joo, et al.
Publicado: (2022)

Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone
por: Distaso, Eugenio, et al.
Publicado: (2021)

Assessment of Therapeutic Response of Edaravone and Riluzole Combination Therapy in Amyotrophic Lateral Sclerosis Patients
por: Samadhiya, Swapnil, et al.
Publicado: (2022)

Investigating Edaravone Use for Management of Amyotrophic Lateral Sclerosis (ALS): A Narrative Review
por: Neupane, Purushottam, et al.
Publicado: (2023)

Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study
por: Park, Jin-Mo, et al.
Publicado: (2022)

First Case of TARDBP-Related Amyotrophic Lateral Sclerosis in Korea
por: Han, Hee Jo, et al.
Publicado: (2020)

Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System
por: Vu, Michelle, et al.
Publicado: (2020)

Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
por: Nourelden, Anas Zakarya, et al.
Publicado: (2023)

Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis
por: Zhang, Fan, et al.
Publicado: (2018)

25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis
por: Kim, Sung-Min, et al.
Publicado: (2017)

Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design
por: Berry, James, et al.
Publicado: (2021)

The Impact of Serum Uric Acid on the Progression of Amyotrophic Lateral Sclerosis in Adults Aged 18 and Older: A Systematic Review
por: Hussein, Sally, et al.
Publicado: (2023)

Serum Uric Acid Levels Predict Mortality Risk in Male Amyotrophic Lateral Sclerosis Patients
por: Xu, Liu-Qing, et al.
Publicado: (2021)

Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
por: Oh, Ki‐Wook, et al.
Publicado: (2018)

Usefulness of diffusion tensor imaging findings as biomarkers for amyotrophic lateral sclerosis
por: Baek, Seol-Hee, et al.
Publicado: (2020)

Effect of Serum Perampanel Concentration on Sporadic Amyotrophic Lateral Sclerosis Progression
por: Kato, Haruhisa, et al.
Publicado: (2023)

Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug
por: Ortiz, Juan Fernando, et al.
Publicado: (2020)

In silico studies reveal structural deviations of mutant profilin-1 and interaction with riluzole and edaravone in amyotrophic lateral sclerosis
por: Sadr, Ahmad Shahir, et al.
Publicado: (2021)

Impaired Perception of Emotional Expression in Amyotrophic Lateral Sclerosis
por: Oh, Seong-il, et al.
Publicado: (2016)

Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)
por: Shefner, Jeremy, et al.
Publicado: (2019)

Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment
por: Genge, Angela, et al.
Publicado: (2022)

Hypolipidemia in Patients with Amyotrophic Lateral Sclerosis: A Possible Gender Difference?
por: Yang, Ji Won, et al.
Publicado: (2013)

Amyotrophic Lateral Sclerosis Is Associated with Hypolipidemia at the Presymptomatic Stage in Mice
por: Kim, Sung-Min, et al.
Publicado: (2011)

Repetitive Nerve Stimulation Test in Amyotrophic Lateral Sclerosis with Predominant Oropharyngeal Manifestations
por: Kim, Jee Young, et al.
Publicado: (2011)

Long-Term Outcome of Amyotrophic Lateral Sclerosis in Korean Subjects
por: Suh, Mi Ri, et al.
Publicado: (2017)

Elimination Rate of Serum Lactate is Correlated with Amyotrophic Lateral Sclerosis Progression
por: Zhang, Yuan-Jin, et al.
Publicado: (2016)

Safety and efficacy of edaravone in well-defined Iranian patients with amyotrophic lateral sclerosis: A parallel-group single-blind trial
por: Eishi-Oskouei, Alireza, et al.
Publicado: (2021)

Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan
por: Houzen, Hideki, et al.
Publicado: (2021)

Abnormal Oculomotor Functions in Amyotrophic Lateral Sclerosis
por: Kang, Bong-Hui, et al.
Publicado: (2018)

Prevention of mitochondrial impairment by inhibition of protein phosphatase 1 activity in amyotrophic lateral sclerosis
por: Choi, So Yoen, et al.
Publicado: (2020)

An animal study to examine the effects of the bilateral, epidural cortical stimulation on the progression of amyotrophic lateral sclerosis
por: Kim, Hyojoon, et al.
Publicado: (2014)

Plasma Uric Acid Helps Predict Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis
por: Tang, Jiahui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g59t9f76qfh5k8o8m2fgtp3jst